閉鎖式薬剤移送システム市場は主に症例の急速な拡大に伴って、非常に高い CAGRで推移しています。長寿に伴って、高齢化による悪性腫瘍が発生しやすくなります。さらに、多くの人が若い頃に喫煙経験があります。そのため年齢とともにさまざまな種類の悪性腫瘍の増殖を引き起こす可能性があります。閉鎖式薬剤移送システムの市場規模は2027 年までに 16 億 2000 万ドルに達し、CAGR は 20.27%になると予想されます。
目次
TABLE OF CONTENT
1 REPORT PROLOGUE
2 MARKET INTRODUCTION
2.1 INTRODUCTION
2.2 ASSUMPTIONS & LIMITATIONS
2.2.1 ASSUMPTIONS
2.2.2 LIMITATIONS
2.3 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 FORECAST MODEL
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 RISING PREVALENCE OF CANCER CASES
4.2.2 INCREASED RISK OF EXPOSURE TO HAZARDOUS DRUGS FOR HEALTHCARE PERSONNEL
4.2.3 SEVERAL SAFETY GUIDELINES AND LEGISLATION FOR THE USE OF CSTD
4.3 RESTRAINTS
4.3.1 HIGH COST
4.3.2 ADVERSE EVENTS AND STATUTORY WARNING BY FDA FOR THE USE OF CSTD
4.4 OPPORTUNITY
4.4.1 EMERGING MARKETS OF CSTD
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF NEW ENTRANTS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 INTENSITY OF RIVALRY
5.2 SUPPLY CHAIN ANALYSIS
5.2.1 R&D
5.2.2 MANUFACTURING
5.2.3 DISTRIBUTION
5.2.4 MARKETING & SALES
5.2.5 POST-SALES MONITORING
5.3 INVESTMENT OPPORTUNITIES
5.4 PRICING ANALYSIS
5.5 MARKETING CHANNEL
5.5.1 DIRECT MARKETING
5.5.2 INDIRECT MARKETING
5.6 REGULATORY AFFAIRS
5.7 COST OF PRODUCTION ANALYSIS
5.7.1 RAW MATERIAL COST ANALYSIS
5.7.2 TECHNOLOGY COST ANALYSIS
5.7.3 LABOR COST ANALYSIS
6 CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
6.1 OVERVIEW
6.1.1 INTRODUCTION
6.1.2 BARRIER-TYPE
6.1.3 FILTRATION-TYPE
7 CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
7.1 OVERVIEW
7.1.1 INTRODUCTION
7.1.2 CLOSED BAG/LINE ACCESS DEVICES
7.1.3 CLOSED VIAL ACCESS DEVICES
7.1.4 CLOSED SYRINGE SAFETY DEVICES
8 CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
8.1 OVERVIEW
8.1.1 INTRODUCTION
8.1.2 SPECIALTY CENTERS
8.1.3 HOSPITALS & CLINICS
9 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION
9.1 INTRODUCTION
9.2 AMERICAS
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.2.1 NORTH AMERICA
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.2.1.1 US
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.2.1.2 CANADA
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.2.1.3 MEXICO
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.2.2 SOUTH AMERICA
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.2.2.1 BRAZIL
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.2.2.2 REST OF SOUTH AMERICA
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.3 EUROPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.3.1 WESTERN EUROPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.3.1.1 GERMANY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.3.1.2 FRANCE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.3.1.3 UK
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.3.1.4 ITALY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.3.1.5 SPAIN
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.3.1.6 REST OF WESTERN EUROPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.3.2 EASTERN EUROPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.4 ASIA-PACIFIC
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.4.1 CHINA
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.4.2 INDIA
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.4.3 JAPAN
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.4.4 AUSTRALIA
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.4.5 SOUTH KOREA
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.4.6 INDONESIA
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.4.7 REST OF ASIA-PACIFIC
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.5 MIDDLE EAST AND AFRICA
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.5.1 MIDDLE EAST
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
9.5.2 AFRICA
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY
CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY DEVELOPMENTS
11 COMPANY PROFILE
11.1 BECTON, DICKINSON AND COMPANY
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS/SERVICES OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS/SERVICES OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 EQUASHIELD LLC
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS/SERVICES OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 ICU MEDICAL INC
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS/SERVICES OFFERED
11.4.4 SWOT ANALYSIS
11.4.5 KEY DEVELOPMENTS
11.4.6 KEY STRATEGIES
11.5 YUKON MEDICAL
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS/SERVICES OFFERED
11.5.4 SWOT ANALYSIS
11.5.5 KEY DEVELOPMENTS
11.5.6 KEY STRATEGIES
11.6 CORVIDA MEDICAL
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS/SERVICES OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
12 APPENDIX
12.1 DISCUSSION BLUE PRINT
